We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Kaléo Promises Generic Naloxone Injector After Blistering Senate Pricing Report
Kaléo Promises Generic Naloxone Injector After Blistering Senate Pricing Report
A month after a scathing congressional report hit Kaléo for hiking prices for its opioid antidote by 600 percent, the company announced it will release a lower-cost generic version of its auto-injector in 2019.